NCT06141967Completed
Evaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital Environment
Source: ClinicalTrials.gov · Last updated 18 Jul 2025
Brief summary (registry, in English)
Diabetes, obesity and metabolic syndrome are closely linked to sleep apnea syndrome. Indeed, diabetic and/or obese patients present an increased risk of sleep apnoea syndrome (SAS), with a prevalence estimated at between 10 and 22%, depending on the study, and most of them requiring treatment with Continuous Positive Airway Pressure (CPAP). In this sub-population of patients, only between 40% and 50% benefit from CPAP.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 600 (actual)
- First submitted
- 9 Nov 2023
- Start date
- 30 Nov 2023
- Primary completion date
- 19 Feb 2025
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Diseases
- Obesity
- NCT number
- NCT06141967
What you commit to
- Study type: Interventional
- Participants enrolled: 600
- From 30 Nov 2023 to the primary completion date, 19 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Known and/or treated OSAS-type respiratory pathology
- No signature of the informed consent form
- Minor or adult patients under guardianship or curatorship
Who the study is looking for
- Adult patients over 18 years old
- Diabetes Mellitus (Type 1 or 2), or obesity (BMI\>30kg/m²) or metabolic syndrome
- Hospitalized for at least one night in the Endocrinology department
- Affiliated or entitled to a social security scheme
- Having received informed information about the study and having co-signed, with the investigator, the informed consent form for participation in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu de Saint Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.